An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing Glioblastoma Cells
Glioblastoma (GBM, WHO grade IV) is an aggressively proliferative and invasive brain tumor that carries a poor clinical prognosis with a median survival of 9 to 12 months. In a prior phosphoproteomic study performed in the U87MG glioblastoma cell line, we identified tyrosine phosphorylation events t...
Main Authors: | , , , , , |
---|---|
Other Authors: | , , , , |
Format: | Article |
Language: | English |
Published: |
Royal Society of Chemistry,
2011-11-16T19:46:36Z.
|
Subjects: | |
Online Access: | Get fulltext |